Joanne Lagmay

Joanne Lagmay, M.D.

Associate Professor; STOP Children's Cancer Of Palm Beach County, Inc. Professorship In Pediatric Oncology

Department: MD-PEDS-HEMATOLOGY
Business Phone: (352) 273-9120
Business Email: jplagmay@peds.ufl.edu

About Joanne Lagmay

Joanne Lagmay, M.D., is board-certified in general pediatrics and pediatric hematology/oncology. Her main focus has been the multidisciplinary treatment of pediatric solid tumors, specifically pediatric sarcoma of the bone and soft tissue. She also has special interest in pediatric palliative care. Dr. Lagmay participates in several national professional societies and committees, including the Children’s Oncology Group, American Society of Pediatric Hematology and Oncology, American Society of Hematology, Connective Tissue Oncologic Society, and STOP Children’s Cancer. Her practice integrates translational research in targeted radionuclide therapies for osteosarcoma in collaboration with UF Veterinary Medicine, Biomedical Engineering, Chemistry, Material Science Engineering and Radiation Oncology. Her direct collaboration with pediatric oncology colleagues in Florida has resulting phase I clinical trials for pediatric cancer patients in the state. Dr. Lagmay came to UF in 2009 from Nationwide Children’s Hospital, The Ohio State University where she was a fellow in pediatric hematology/oncology. She did her pediatric residency training at the Children’s Hospital of Monmouth in New Jersey, where she also served as chief resident.

Accomplishments

Excellence in Medical Student teaching
2011-2009 · unknown
Outstanding Achievement for Medical Student Education
2010-2011 · unknown
Physician Customer Service Recognition
2009 · unknown

Board Certifications

  • Pediatric Hematology/Oncology
    American Board of Pediatrics
  • Pediatrics
    American Board of Pediatrics

Clinical Profile

Specialties
  • Pediatrics
Subspecialties
  • Hospice and Palliative Medicine
  • Pediatric Hematology-Oncology
Areas of Interest
  • Adult soft tissue sarcoma
  • Bone tumor
  • Ewing sarcoma
  • Gynecological Cancer
  • Head and Neck Cancer
  • Neuroblastoma
  • Osteosarcoma
  • Renal cell carcinoma
  • Rhabdomyosarcoma
  • Wilms tumor

Publications

2020
Chordoma of the Clivus and Acute Myeloid Leukemia: Is There a Connection?
Journal of Pediatric Hematology/Oncology. 42(7):E662-E664 [DOI] 10.1097/MPH.0000000000001659.
2020
Malignant round cell tumor with SS18-POU5F1 fusion: is it a myoepithelial neoplasm, a synovial sarcoma or a new entity?
Histopathology. 77(4):681-684 [DOI] 10.1111/his.14171. [PMID] 32516451.
2020
Primary mediastinal infantile fibrosarcoma: An unusual presentation involving the thymus.
Pediatric blood & cancer. 67(11) [DOI] 10.1002/pbc.28402. [PMID] 32735378.
2020
Primary pulmonary artery sarcoma in the pediatric patient: Review of literature and a case report.
Radiology case reports. 15(7):1110-1114 [DOI] 10.1016/j.radcr.2020.05.016. [PMID] 32477441.
2020
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung.
Sarcoma. 2020 [DOI] 10.1155/2020/7935475. [PMID] 32398945.
2019
Emerging trends in immunotherapy for pediatric sarcomas.
Journal of hematology & oncology. 12(1) [DOI] 10.1186/s13045-019-0756-z. [PMID] 31311607.
2019
Radiation Treatment for Ewing Sarcoma Family of Tumors in Adult Patients: A Single Institution’s Experience Over 40 Years.
American journal of clinical oncology. 42(5):421-425 [DOI] 10.1097/COC.0000000000000532. [PMID] 30883389.
2016
Left Ventricular Metastasis in Neuroblastoma: A Case Report.
Journal of pediatric hematology/oncology. 38(1):74-7 [DOI] 10.1097/MPH.0000000000000439. [PMID] 26479997.
2016
Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children’s Cancer Group, Pediatric Oncology Group, and Children’s Oncology Group: Learning From the Past to Move Forward.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(25):3031-8 [DOI] 10.1200/JCO.2015.65.5381. [PMID] 27400942.
2014
Advances in therapy for pediatric sarcomas.
Current oncology reports. 16(8) [DOI] 10.1007/s11912-014-0395-z. [PMID] 24894064.
2014
Synthesis of polymeric phosphonates for selective delivery of radionuclides to osteosarcoma.
Cancer biotherapy & radiopharmaceuticals. 29(7):273-82 [DOI] 10.1089/cbr.2014.1615. [PMID] 25111903.
2011
Adjuvant radiotherapy for pediatric and young adult nonrhabdomyosarcoma soft-tissue sarcoma.
International journal of radiation oncology, biology, physics. 81(1):150-7 [DOI] 10.1016/j.ijrobp.2010.05.005. [PMID] 21550181.
2011
Chest wall Ewing sarcoma family of tumors: long-term outcomes.
International journal of radiation oncology, biology, physics. 81(1):158-66 [DOI] 10.1016/j.ijrobp.2010.04.066. [PMID] 20732765.
2011
External-beam radiotherapy for pediatric and young adult desmoid tumors.
Pediatric blood & cancer. 57(3):435-42 [DOI] 10.1002/pbc.22916. [PMID] 21744472.
2009
Clear cell sarcoma of the stomach.
Pediatric blood & cancer. 53(2):214-6 [DOI] 10.1002/pbc.22014. [PMID] 19350639.
2009
Primary testicular presentation of ALK-1-negative anaplastic large cell lymphoma in a pediatric patient.
Journal of pediatric hematology/oncology. 31(5):330-2 [DOI] 10.1097/MPH.0b013e3181979c5e. [PMID] 19415011.
2009
Prognostic significance of interleukin-6 single nucleotide polymorphism genotypes in neuroblastoma: rs1800795 (promoter) and rs8192284 (receptor).
Clinical cancer research : an official journal of the American Association for Cancer Research. 15(16):5234-9 [DOI] 10.1158/1078-0432.CCR-08-2953. [PMID] 19671870.
2007
Familiarity of pediatricians with different commercially available neonatal and infant formulas.
Clinical pediatrics. 46(5):418-23 [PMID] 17556738.
View on: PubMed
1999
Cytopathogenicity of Acanthamoeba isolates on rat glial C6 cell line.
The Southeast Asian journal of tropical medicine and public health. 30(4):670-7 [PMID] 10928358.
View on: PubMed

Grants

Jul 2012 – Jun 2016
A Phase I Trial of Dose Escalation of Metformin in Combination with Vincristine, Irinotecan and Temozolomide in Chidlren with RElapsed or Refractory Solid Tumors
Role: Principal Investigator
Funding: H LEE MOFFITT CANCER CTR via PEDIATRIC CANCER RESEARCH FOU

Education

Residency – Pedicatric Hematology/Oncology
2009 · Nationwide Children's Hospital
Residency – Pediatrics
2006 · Children's Hospital at MonMouth Medical Center
Medical Degree
2002 · University of the Philippines

Teaching Profile

Courses Taught
2018
MDC7400 Pediatric Clerkship
2018
MDC7401 Senior Pediatric Clk
2018
MDT7400 Elect Top/Pediatrics

Contact Details

Phones:
Business:
(352) 273-9120
Emails: